Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 116
Age Group: 18 Years to 90 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double Blind (Participant, Care Provider, Investigator)|Primary Purpose: Treatment
Study ID Numbers: EORTC-08112
Study First Received: August 8, 2016
Last Updated: August 10, 2016
Estimated Primary Completion Date: February 2019
Primary Outcome Measures:
Progression-free survival|Overall survival|Overall Response Rate
Sponsors and Collaborators:
European Organisation for Research and Treatment of Cancer – EORTC
Website Link: https://ClinicalTrials.gov/show/NCT02863055
